Maria Sharapova: The Loudest Player in Tennis
On her fourteenth birthday she turned professional; the following week she played her first tournament, an ITF clay event in Sarasota, Florida. Three years and two months later she was standing on Centre Court having beaten Serena Williams, the defending champion, in a Wimbledon final. Almost nothing about the twenty years that followed was accidental — including the parts that went badly.
Nyagan to Bradenton
Maria Sharapova was born on 19 April 1987 in Nyagan, in Siberia. She was handed her first racquet in 1991, a gift from Aleksandr Kafelnikov, of one of Russian tennis's established families. Her own family's response to what they saw was drastic: by 1995 Sharapova was in Florida at the IMG Academy, working under Nick Bollettieri. She turned professional on her fourteenth birthday, 19 April 2001.
Centre Court, 2004
The 2004 Wimbledon final is the match that fixed her in the public mind, and it was an upset by any measure: a seventeen-year-old beating Serena Williams, the defending champion. It was not a fluke either. Later that year, at the season-ending WTA Finals in Los Angeles, Sharapova beat Williams again. On 22 August 2005 she became world number one. What followed, though, was less linear than the start suggested. She would hold the top ranking across five separate spells — twenty-one weeks in total by the International Tennis Hall of Fame's count, eighteen by the WTA's — a modest tally for a player who would win five majors, and a signal of how contested the era around her was.
The Grind
The second and third majors came from different surfaces and different problems. At the 2006 US Open she beat Justine Henin in the final as the third seed. At the 2008 Australian Open she went through the entire draw without dropping a set, finishing off Ana Ivanovic. Then her body intervened: a second shoulder surgery in August 2009 took out the shot that had made everything else work. Rebuilding a serve at twenty-two, in public, against opponents who had watched you do it the first time, is the least glamorous work in professional sport. She spent 408 weeks in the WTA's top five, a figure that says more about her durability than any single title does.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Roland Garros, Twice
The unlikeliest chapter is the clay one. Sharapova's game — flat, upright, built on hitting through the court — was theoretically the worst possible fit for a slow surface, and she was written off on it for years. She then won Roland Garros in 2012, completing the career Grand Slam, and won it again in 2014, beating Simona Halep in the final. In between she took three consecutive titles on the indoor clay of Stuttgart, from 2012 to 2014. Her final clay record reads eleven wins from thirteen title matches. She also took Olympic silver in the singles at London 2012 and played Fed Cup for Russia in 2008, 2011, 2012 and 2015, going 7-1 in singles. The career ledger closed at 645 wins and 171 losses, with thirty-six singles titles, fourteen of them at WTA 1000 level.
Meldonium
In January 2016 she tested positive for meldonium, a heart drug that had moved onto the banned list at the start of that year after she had been taking it for years. The initial sanction was two years; the Court of Arbitration for Sport reduced it to fifteen months on appeal, and she returned to the tour in 2017. The commercial fallout was narrower than expected — Tag Heuer walked away, while Nike, Evian, Head, Porsche and UBS did not — but the reputational damage was permanent in a way the ranking points were not. She retired in February 2020, writing that "tennis showed me the world — and it showed me what I was made of."
The Business
The other career ran in parallel and, financially, dwarfed the first. Sharapova finished with $325 million in total earnings, second all-time among female athletes behind Serena Williams. Of that, prize money accounted for $38 million; the remaining $287 million came from endorsements and appearances. She was Forbes' highest-paid female athlete for eleven consecutive years, peaking near $30 million in 2015, with a portfolio that ran from Nike, Prince and Canon to Land Rover, PepsiCo and Sony. In 2012 she launched Sugarpova, a confectionery line that became a lifestyle brand and was on target for $20 million in revenue by 2019. She served as a United Nations Development Programme Goodwill Ambassador and founded the Maria Sharapova Foundation. Her son, Theodore, was born in 2022. In 2025 she was inducted into the International Tennis Hall of Fame.
Why Maria Is Called a Genius
The word does not fit her the way it fits a chess player, and pretending otherwise would be dishonest. Sharapova was not the most gifted player of her generation — she was routinely out-athleted, and the sources do not record anyone in the game calling her a natural. What she had instead was two forms of applied intelligence, and both are unusually well documented.
The first is competitive problem-solving. Her game was a poor theoretical fit for clay, and she solved clay anyway: two French Open titles, three straight Stuttgart titles, eleven wins from thirteen clay finals. She lost her serve to shoulder surgery in 2009 and constructed a different route to winning majors afterwards, taking Roland Garros in 2012 and 2014 with a body that no longer did what it had at seventeen. That is analytical work, not talent.
The second is commercial. Turning $38 million of prize money into $287 million of endorsements, and building Sugarpova into a $20 million business while still playing, reflects an accurate reading of her own market value that very few athletes of any sport manage.
The counter-case is substantial. Twenty-one weeks at world number one across a twenty-year career is a thin return for five majors, and it suggests a player who peaked in bursts rather than sustained dominance. Her two great wins over Serena Williams both came in 2004; when they met in the 2012 WTA Finals, Williams won. And a fifteen-month doping suspension, however sympathetically one reads the circumstances, is a fact that any honest account has to carry. What survives is not brilliance but relentlessness applied with real intelligence — a different and rarer thing than it sounds.
Legacy
Sharapova's importance is partly a matter of what she demonstrated to everyone who came after her: that a professional tennis career is a business with a playing division attached. She won on every surface, came back from surgery and suspension, and left the sport at thirty-two having reorganised the economics of being a female athlete. The Hall of Fame took her in 2025, twenty-one years after Centre Court.
Achievements
- Medal of the Order "For Merit to the Fatherland", 2nd class without swords
- Medal of the Order "For Merit to the Fatherland", 1st class
- Competed at the 2012 Summer Olympics
